- Today's Hot Chat Topics
- Member Benefits
- Manage your personalised Watchlist.
- Set up an online Virtual Portfolio.
- Participate in Share Chat.
- See more trades and director dealings.
- Play the Fantasy Share Trading Game.
Share:
HomeShare PricesStock PickerFinancial DiaryUK IndicesUK Industry SectorsCompany LookupShare RisersShare FallersBroker RatingsFinance GlossarySMS ServicesShare ChatFinance NewsBlogsLive PricesShares BookshopFinance ToolsMembers
Latest Share Chat
Shire Regulatory News (SHP)
Regulatory News for Shire (SHP)
| Share Price: 2,168.00 | Bid: 2,164.00 | Ask: 2,166.00 | Change: 0.00 (0.00%) |  | ||||||
| ||||||||||
First quarter 2012 results date notification
Thu, 12th Apr 2012 16:15
First quarter 2012 results date notification - April 26, 2012
Dublin, Ireland - April 12, 2012 - Shire plc
Results press release will be 12:00 BST / 07:00 EDT
issued at:
Investor conference call time: 14:00 BST / 09:00 EDT
Live conference call for investors:
Angus Russell, Chief Executive Officer and Graham Hetherington, Chief Financial
Officer will host the investor and analyst conference call at 14:00 BST/9:00
EDT.
The details of the conference call are as follows:
UK dial in: 0800 077 8492 or 0844 335 0351
US dial in: 1 866 8048688 or 1 718 3541175
International dial in: +44 844 335 0351
Global Access Numbers: http://www.btconferencing.com/globalaccess/?bid=54_attended
Password/Conf ID: 338 270
Live Webcast: http://www.shire.com/shireplc/en/investors
Replay:
A replay of the presentation will be available for two weeks by phone and by
webcast for one year. Details can be found on our Investor Relations website
http://www.shire.com/shireplc/en/investors.
For further information please contact:
Investor Relations Souheil Salah ssalah@shire.com +44 1256 894 160
Erin K. Kelly erikelly@shire.com +1 781 482 9541
Notes to editors
SHIRE PLC
Shire's strategic goal is to become the leading specialty biopharmaceutical
company that focuses on meeting the needs of the specialist physician. Shire
focuses its business on attention deficit hyperactivity disorder, human genetic
therapies, gastrointestinal diseases and regenerative medicine as well as
opportunities in other therapeutic areas to the extent they arise through
acquisitions. Shire's in-licensing, merger and acquisition efforts are focused
on products in specialist markets with strong intellectual property protection
and global rights. Shire believes that a carefully selected and balanced
portfolio of products with strategically aligned and relatively small-scale
sales forces will deliver strong results.
For further information on Shire, please visit the Company's website:
www.shire.com.
Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PX
Press Release
www.shire.com
| Date | Source | Headline | Category |
|---|---|---|---|
| 24-May-13 07:00 | PRN | Transaction in Own Shares | Transaction in Own Shares |
| 23-May-13 15:30 | PRN | Block Listing Six Monthly Return | Company Announcement - General |
| 23-May-13 07:00 | PRN | Transaction in Own Shares | Transaction in Own Shares |
| 21-May-13 07:00 | PRN | Transaction in Own Shares | Transaction in Own Shares |
| 16-May-13 07:00 | PRN | Transaction in Own Shares | Transaction in Own Shares |
| 09-May-13 16:58 | PRN | Shire Wins Patent Trial Against Watson concerning LIALDA | Company Announcement - General |
| 09-May-13 07:00 | PRN | Transaction in Own Shares | Transaction in Own Shares |
| 08-May-13 15:00 | PRN | Purchase of Shares by Employee Benefit Trust | Transaction in Own Shares |
| 08-May-13 07:00 | PRN | Transaction in Own Shares | Transaction in Own Shares |
| 07-May-13 07:00 | PRN | Transaction in Own Shares | Transaction in Own Shares |
| 03-May-13 14:45 | PRN | Director’s Share Dealings | Directors' Dealings |
| 03-May-13 07:00 | PRN | Transaction in Own Shares | Transaction in Own Shares |
| 02-May-13 12:00 | PRN | New CEO reports Q1 and sets out strategy for growth | Results and Trading Reports |
| 02-May-13 07:00 | PRN | Transaction in Own Shares | Transaction in Own Shares |
| 01-May-13 12:00 | PRN | Total Voting Rights | Holding(s) in Company |
| 30-Apr-13 16:00 | PRN | Results of the 2013 Annual General Meeting | Results and Trading Reports |
| 30-Apr-13 07:00 | PRN | Transaction in Own Shares | Transaction in Own Shares |
| 29-Apr-13 16:30 | PRN | Director Declaration | Executive Changes |
| 26-Apr-13 07:00 | PRN | Transaction in Own Shares | Transaction in Own Shares |
| 25-Apr-13 14:26 | PRN | Shire Settles INTUNIV Litigation with Actavis and Watson | Company Announcement - General |
| 25-Apr-13 07:00 | PRN | Transaction in Own Shares | Transaction in Own Shares |
| 24-Apr-13 07:00 | PRN | Transaction in Own Shares | Transaction in Own Shares |
| 23-Apr-13 07:00 | PRN | Transaction in Own Shares | Transaction in Own Shares |
| 19-Apr-13 07:00 | PRN | Transaction in Own Shares | Transaction in Own Shares |
| 18-Apr-13 14:30 | PRN | First quarter 2013 results date notification | Advance Notice of Results |
| 18-Apr-13 07:00 | PRN | Blocklisting - Interim Review | Company Announcement - General |
| 18-Apr-13 07:00 | PRN | Transaction in Own Shares | Transaction in Own Shares |
| 16-Apr-13 07:00 | PRN | SHIRE PLC - Transaction in Own Shares | Transaction in Own Shares |
| 12-Apr-13 07:00 | PRN | SHIRE PLC - Transaction in Own Shares | Transaction in Own Shares |
| 11-Apr-13 07:00 | PRN | SHIRE PLC - Transaction in Own Shares | Transaction in Own Shares |
Regulatory news is displayed end of day, each day at 19:00.
